For the treatment of failure of passive transfer (FPT) and/or as an aid
in the management and control of respiratory disease associated with
Rhodococcus equi. Intended for use in foals less than 6 months of age.
Minimum IgG level of 2400 mg/dL. Available in 950ml bags. The first USDA
licensed combination plasma for this purpose.